Cross-cultural validation and measurement invariance of anxiety and depression symptoms: A study of the Brief Symptom Inventory (BSI) in 42 countries
Impact
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/8033
comunitat-uji-handle3:10234/8636
comunitat-uji-handle4:
INVESTIGACIONThis resource is restricted
https://doi.org/10.1016/j.jad.2024.01.127 |
Metadata
Title
Cross-cultural validation and measurement invariance of anxiety and depression symptoms: A study of the Brief Symptom Inventory (BSI) in 42 countriesAuthor (s)
Date
2024-02-01Publisher
ElsevierISSN
0165-0327; 1573-2517Bibliographic citation
Quintana, G. R., Ponce, F. P., Escudero-Pastén, J. I., Santibáñez-Palma, J. F., Nagy, L., Koós, M., ... & Bőthe, B. (2024). Cross-cultural validation and measurement invariance of anxiety and depression symptoms: A study of the Brief Symptom Inventory (BSI) in 42 countries. Journal of affective disorders, 350, 991-1006.Type
info:eu-repo/semantics/articleVersion
info:eu-repo/semantics/publishedVersionSubject
Abstract
Background
Depression and anxiety are among the most prevalent mental health issues experienced worldwide. However, whereas cross-cultural studies utilize psychometrically valid and reliable scales, fewer can meani ... [+]
Background
Depression and anxiety are among the most prevalent mental health issues experienced worldwide. However, whereas cross-cultural studies utilize psychometrically valid and reliable scales, fewer can meaningfully compare these conditions across different groups. To address this gap, the current study aimed to psychometrically assess the Brief Symptomatology Index (BSI) in 42 countries.
Methods
Using data from the International Sex Survey (N = 82,243; Mage = 32.39; SDage = 12.52; women: n = 46,874; 57 %), we examined the reliability of depression and anxiety symptom scores of the BSI-18, as well as evaluated evidence of construct, invariance, and criterion-related validity in predicting clinically relevant variables across countries, languages, genders, and sexual orientations.
Results
Results corroborated an invariant, two-factor structure across all groups tested, exhibiting excellent reliability estimates for both subscales. The ‘caseness’ criterion effectively discriminated among those at low and high risk of depression and anxiety, yielding differential effects on the clinical criteria examined.
Limitations
The predictive validation was not made against a clinical diagnosis, and the full BSI-18 scale was not examined (excluding the somatization sub-dimension), limiting the validation scope of the BSI-18. Finally, the study was conducted online, mainly by advertisements through social media, ultimately skewing our sample towards women, younger, and highly educated populations.
Conclusions
The results support that the BSI-12 is a valid and reliable assessment tool for assessing depression and anxiety symptoms across countries, languages, genders, and sexual orientations. Further, its caseness criterion can discriminate well between participants at high and low risk of depression and anxiety. [-]
Is part of
Journal of Affective Disorders 350 (2024) 991–1006Funder Name
WUN Research Development Fund (RDF) 2021 | Higher Education Sprout Project | Ministry of Education at the Headquarters of University Advancement at the National Cheng Kung University (NCKU) | Chaire Professeur Junior of Artois University and by the Strategic Dialogue and Management Scholarship | Japan Society for The Promotion of Science | Smoking Research Foundation | Kindbridge Research Institute | Charles University institutional support programme Cooperatio-Health Sciences | National Science Centre, Poland | Hauts-de-France Regional Council (France) | National Social Science Foundation of China | New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund.; MG was supported by National Science Centre, Poland | Hungarian National Research, Development, and Innovation Office
Project code
SNI #073–2022 | JP21H05173 | 21H02849 | 23K07013 | 2020/36/C/HS6/00005 | DSG2 | Grant No. 19BSH117 | ÚNKP-22-3 | 2021/40/Q/HS6/00219 | ÚNKP-22-3 | KKP126835
Rights
0165-0327/© 2024 Elsevier B.V. All rights reserved.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
This item appears in the folowing collection(s)
- PSB_Articles [1315]